المشهد
America and Iran Send Mixed Signals at Doha Talks
Israeli army closes charity HQ and destroys sports field in West Bank
Chinese Vice President holds talks with Saudi Foreign Minister
Qatari Foreign Ministry: Witteckoff and Kushner in Doha without Iran talks
Implications of Calabria Mafia Boss "Don Mico" Fall
المصدر: المشهد
2 Daysجاهز للتشغيل
جاهز للتشغيل
News reports circulated that Trump is receiving secret treatment for obesity using the drug "Rettrutide," despite the fact that the U.S. Food and Drug Administration has not yet approved it. This topic sparked widespread controversy regarding the possibility of obtaining experimental medications prior to official approvals, especially since the law allows for such access in exceptional cases through the "Expanded Access" pathway. An official statement denied any connection between Trump and the drug. However, the incident revealed how certain figures can access new medications before they are publicly available, amidst an unregulated market profiting from the demand for drugs before final approval. "Rettrutide" is considered a promising future medication for treating obesity, as it activates three hormonal mechanisms, leading to significant weight loss results.
تنويه: هذا ملخص تم إنشاؤه بواسطة الذكاء الاصطناعي
comments.heading